← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Antitrombina iii umana currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: ANTITROMBINA III UMANA · data refreshed 10 September 2026
As of 10 September 2026, 1 of the 9 tracked registers list current availability issues for Antitrombina iii umana, covering 4 affected product presentations. The longest-running open report was filed in Italy on 2024-11-30 and has now been open for about 22 months. Where agencies state a cause, manufacturing problems lead with 2 of the 4 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-31. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage ANBINEX + 3 more productsANBINEX ANTITROMBINA III BAXALTA ATENATIV | 2024-11-30 | 2026-12-31 | Problemi produttivi: ridotta disponibilità Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Antitrombina iii umana in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | ANBINEX | Shortage | 2025-07-25 | 2026-08-31 | Problemi produttivi: ridotta disponibilità |
| 🇮🇹 IT | ANBINEX | Shortage | 2025-07-11 | 2026-08-31 | Problemi produttivi: ridotta disponibilità |
| 🇮🇹 IT | ATENATIV | Shortage | 2025-06-01 | 2026-12-31 | Elevata richiesta |
| 🇮🇹 IT | ANTITROMBINA III BAXALTA | Shortage | 2024-11-30 | — | Cessata commercializzazione temporanea: disponibili solo con |
Yes. As of 10 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
4 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Antitrombina iii umana: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Antitrombina iii umana — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/antitrombina-iii-umana/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Antitrombina iii umana availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/antitrombina-iii-umana/">Antitrombina iii umana shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>